Skip to main content
. 2011 Sep 13;105(8):1176–1182. doi: 10.1038/bjc.2011.369

Table 2. Her2/neu expression and Her2/neu ECD release in the media supernatants of uterine serous tumours.

      RT–PCR Flow cytometry
sHer2/neu
  IHC FISH mRNA copy no. % Gated MFI ng ml−1 per 96 h
USPC-ARK-1 3+ 2.5a 2749.5 99.8 339.5 4.2 × 10−6
USPC-ARK-2 3+ 5.2a 4478.9 99.9 710.3 4.9 × 10−6
USPC-ARK-3 3+ 4.7a 4993.8 99.9 228.7 3.4 × 10−6
USPC-ARK-9 3+ 4.6b 4326.5 99.3 285.7 9.1 × 10−6
USPC-ARK-10 3+ 4.3b 549.8 98.8 25.4 1.6 × 10−6
USPC-ARK-7 2+ 1.3b 45.6 94.9 47.4 0
USPC-ARK-6 1+ 0.9a 44.3 93.4 13.0 0
USPC-ARK-8 1+ 1.6b 17.6 83.2 24.8 0
USPC-ARK-4 1+ 1.6a 52.8 95.2 10.8 0
USPC-ARK-5 1+ 1.4a 95.3 83.8 18.7 0
BT-474 3+ Amplified 897 99.9 654.9 6.4 × 10−6
SK-BR-3 3+ Amplified 932 99.9 265.4 2.89 × 10−6

Abbreviations: FISH=fluorescent in situ hybridisation; IHC=immunohistochemistry; RT–PCR=real-time PCR; MFI=mean fluorescence intensity; USPC=uterine serous papillary adenocarcinoma; sHer2/neu=soluble Her2/neu.

a

FISH analysis performed on formalin-fixed, paraffin-embedded cell blocks obtained from primary cell lines in culture.

b

FISH performed on formalin-fixed, paraffin-embedded tissue blocks of the original tumour sample.